IRIS - Res&Arch Institutional Research Information System - Research & Archive

FELICETTI, TOMMASO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.609
AS - Asia 1.397
EU - Europa 1.160
SA - Sud America 168
AF - Africa 33
OC - Oceania 3
Totale 4.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.570
SG - Singapore 711
IT - Italia 494
CN - Cina 179
HK - Hong Kong 179
RU - Federazione Russa 156
IE - Irlanda 154
BR - Brasile 125
VN - Vietnam 115
DE - Germania 65
FR - Francia 62
KR - Corea 46
BD - Bangladesh 35
BE - Belgio 34
FI - Finlandia 32
SE - Svezia 31
GB - Regno Unito 29
CA - Canada 22
IN - India 20
NL - Olanda 17
IQ - Iraq 16
PL - Polonia 14
AR - Argentina 13
JP - Giappone 13
ID - Indonesia 12
MX - Messico 12
ZA - Sudafrica 12
ES - Italia 11
TR - Turchia 10
UA - Ucraina 10
PK - Pakistan 9
SA - Arabia Saudita 9
AT - Austria 8
PT - Portogallo 8
RO - Romania 8
CZ - Repubblica Ceca 7
EC - Ecuador 7
VE - Venezuela 7
CO - Colombia 6
UZ - Uzbekistan 6
CL - Cile 5
TN - Tunisia 5
AZ - Azerbaigian 4
CH - Svizzera 4
LB - Libano 4
PH - Filippine 4
ET - Etiopia 3
IR - Iran 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
RS - Serbia 3
AO - Angola 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
PY - Paraguay 2
QA - Qatar 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
IL - Israele 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 4.370
Salva come PNG Salva come JPEG
Città #
Singapore 544
Perugia 315
San Jose 230
Chandler 221
Hong Kong 174
Dublin 154
Ashburn 106
Santa Clara 71
Boardman 59
Moscow 46
San Mateo 44
Seoul 44
Lauterbourg 40
Los Angeles 40
Altamura 39
New York 38
The Dalles 38
Brussels 34
Ho Chi Minh City 34
Beijing 32
Medford 29
Princeton 29
Lawrence 27
Dong Ket 25
Council Bluffs 22
Munich 22
Redmond 21
Wilmington 20
Piscataway 17
Spoleto 17
Hanoi 16
Orem 16
Redwood City 15
São Paulo 14
Brooklyn 13
Dallas 12
Turku 11
Warsaw 11
Andover 10
Denver 10
Des Moines 10
Helsinki 10
Nuremberg 10
Tokyo 10
Bologna 9
Fremont 9
Hefei 9
Montreal 9
Phoenix 9
San Giustino 9
Ann Arbor 8
Baghdad 8
Columbus 8
Lappeenranta 8
Rome 8
West Jordan 8
Atlanta 7
Bucharest 7
Houston 7
Secaucus 7
Amsterdam 6
Buffalo 6
Dhaka 6
Mexico City 6
Olomouc 6
Saint Petersburg 6
Shanghai 6
Vienna 6
Chennai 5
Chicago 5
Florence 5
Guangzhou 5
Haiphong 5
Jakarta 5
Johannesburg 5
London 5
Milan 5
Norwalk 5
San Francisco 5
Seattle 5
Turin 5
Ankara 4
Cape Town 4
Da Nang 4
Guarda 4
Hanover 4
Jeddah 4
Ninh Bình 4
Querétaro 4
Riyadh 4
Stockholm 4
Tashkent 4
Toronto 4
Tunis 4
Xian 4
Addis Ababa 3
Amman 3
Baku 3
Biên Hòa 3
Boston 3
Totale 3.014
Salva come PNG Salva come JPEG
Nome #
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 204
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 153
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 140
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 137
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 134
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 129
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 127
Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors 120
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 117
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 115
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 115
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 113
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 113
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 112
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation 107
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 104
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 103
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 102
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 100
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 100
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 99
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations 95
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs 93
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 89
Building up efflux-mediated antimicrobial resistance in Staphylococcus pseudintermedius 89
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 89
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes 86
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance 84
In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains 79
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 77
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 74
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 74
Virucidal Activity of the Pyridobenzothiazolone Derivative HeE1-17Y against Enveloped RNA Viruses 70
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 70
Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives 70
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 66
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 63
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents 60
EVALUATION OF DRUG EFFLUX ACTIVITY IN ANTIMICROBIAL RESISTANT STAPHYLOCOCCUS PSEUDINTERMEDIUS CLINICAL ISOLATES 59
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives 57
Targeting miRNA dysregulation with small molecules: The case of enoxacin 57
Protein-protein interactions by influenza polymerase subunits as drug targets 56
Role and regulation of membrane efflux pumps in Staphylococcus pseudintermedius clinical isolates 56
Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination 48
Streamlined Synthesis and Structure–Activity Relationship Analysis of 2‐Amidothiophene‐3‐Carboxamides Targeting Influenza Polymerase PA‐PB1 Heterodimerization 19
New Pyridobenothiazolone Derivatives Display Nanomolar Pan‐Serotype Anti‐Dengue Virus Activity 18
2-Phenylquinolines Exhibit Anti-Severe Acute Respiratory Syndrome Coronavirus-2 Activity Through the Nonstructural Protein 13 Helicase Inhibition 5
Sulfonyl Anthranilic Acid Analogues Display Pan-Serotype Anti-Dengue Activity by Downregulating the Expression of Ribosomal Proteins Encoded by 5′-Terminal Oligopyrimidine Motif-Containing mRNA 3
Broad-Spectrum Antiviral Activity of Pyridobenzothiazolone Analogues Against Respiratory Viruses 1
Totale 4.594
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/2022311 10 35 6 11 13 2 44 69 29 16 30 46
2022/2023617 30 128 7 67 45 72 0 28 191 10 29 10
2023/2024339 20 54 16 5 8 12 93 7 14 26 36 48
2024/20251.047 15 64 40 88 83 95 217 87 147 44 111 56
2025/20261.985 126 126 101 214 262 176 359 110 215 153 98 45
Totale 4.594